nauchnyy_seminar

Pharmasyntez asks Russian Government for permission to produce generic version of remdesivir for COVID-19

November 2, 2020
Sales and Marketing

Russian drug firm Pharmasyntez has asked the government for permission to produce a generic version of Gilead’s remdesivir without a …

shutterstock_273326141

Sanofi angles to buy Kiadis for €308 million

November 2, 2020
Sales and Marketing Sanofi, kiadis, pharma

Sanofi has announced it is poised to buy out Amsterdam-based biopharma firm Kiadis in an all-cash public offer of €308 …

dermatitis2015_-_copy

LEO Pharma’s delgocitinib hits main goals in moderate-to-severe chronic hand eczema

November 2, 2020
Research and Development, Sales and Marketing LEO Pharma, eczema, pharma

LEO Pharma has revealed new Phase 2b at the European Academy of Dermatology and Venereology (EADV) Virtual 2020 Virtual Congress …

parag_agarwal_-17485

Parag Agarwal appointed as Dr Reddy’s Laboratories Chief Financial Officer

October 30, 2020
Sales and Marketing

Dr Reddy’s Laboratories has appointed Parag Agarwal has the company’s new Chief Financial Officer. Parag has a career that spans …

nice_new_london_office_internal_3_web

NICE recommends Novo’s liraglutide for management of obesity and non-diabetic hyperglycaemia

October 30, 2020
Medical Communications, Sales and Marketing NICE, Novo Nordisk, liraglutide

Novo Nordisk’s pre-filled injection Saxenda (liraglutide) has received the backing of drug watchdog NICE, meaning it will now be made …

shutterstock_87495637

AstraZeneca jettisons two heart drugs to Cheplapharm in $400m deal

October 30, 2020
Manufacturing and Production, Medical Communications, Sales and Marketing AstraZeneca, Cheplapharm

AstraZeneca is set to sell the rights to its AT1 subtype angiotensin II receptor antagonist Atacand (candesartan cilexetil) and Atacand …

800px-european_commission_flags_1

EU approves Zejula as a first-line monotherapy maintenance treatment in advanced ovarian cancer

October 30, 2020
Medical Communications

The European Commission has approved GlaxoSmithKline’s Zeljula as a first line monotherapy maintenance treatment for adult patients with ovarian cancer …

49798220211_23b94b0fb8_b

New study suggests UK Government’s ‘Eat Out to Help Out’ scheme increased coronavirus infection rates

October 30, 2020
Medical Communications

The Eat Out to Help Out scheme contributed to a significant rise in new coronavirus cases according to a study …

top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

October 30, 2020
Medical Communications

The top ten news stories this week focus on COVID-19 studies, as new research has found that over 80% of …

heinz-woodward-front1

David Woodward joins GAMA Healthcare as Board Business Advisory Consultant and CEO Mentor

October 29, 2020
Business Services

GAMA Healthcare have announced that David Woodward has been brought on as Board Business Advisory Consultant and CEO Mentor. Woodward …

europe-1395916_640

European Commission greenlights Insmed’s Arikayce for nontuberculous mycobacterial lung infections

October 29, 2020
Sales and Marketing Arikayce, EU, lungs, pharma

The European Commission (EC) has given approval to Insmed Incorporated’s Arikayce (liposomal 590mg nebuliser dispersion) for the treatment of nontuberculous …

tumour-infiltrating_lymphocytes_-_2_--_very_high_mag

NICE says test people with womb cancer for Lynch syndrome

October 29, 2020
Medical Communications

New guidance from the National Institute of Health and Care Excellence says that women with womb cancer should be tested …

800px-social_distancing_queueing_for_the_supermarket_j

Nearly 100,000 people catching coronavirus every day in England, new study suggests

October 29, 2020
Research and Development

Nearly 100,000 people are being infected with COVID-19 each day according to a new study from Imperial College London.  Named …

bugbuster

FDA approves Sanofi’s ivermectin head lice treatment for over-the-counter use

October 29, 2020
Sales and Marketing

The FDA has approved Sanofi’s Sklice (ivermectin) for over-the-counter use.  Sklice is a single-use lotion that includes ivermectin 0.5% as …

takeda_usa_pharmaceuticals_u

Takeda commits to deliver 50 million doses of Moderna’s COVID-19 vaccine in Japan

October 29, 2020
Manufacturing and Production, Sales and Marketing COVID-19, Japan, Moderna, Takeda, Vaccine

Takeda has made a commitment with Japan’s Ministry of Health, Labor and Welfare (MHLW) to deliver 50 million doses of …

robertson_1

Redx Pharma appoints Dr Jane Robertson as Chief Medical Officer

October 29, 2020
Research and Development

Redx Pharma has announced the appointment of Dr Jane Robertson as its new Chief Medical Officer at the company. Robertson …

vaccination-1215279_960_720

GSK and Sanofi promise 200m COVID-19 vaccines to international COVAX initiative

October 28, 2020
Manufacturing and Production, Research and Development COVAX, COVID-19, GSK, Sanofi

Sanofi and GSK have committed 200 million doses of their adjuvanted recombinant protein-based COVID-19 vaccine to the COVAX Facility, a …

Novartis collaborates with Molecular Partners to develop therapies to use against COVID-19

October 28, 2020
Research and Development

Novartis and Molecular Partners AG have announced that they will develop, commercialise and manufacture Molecular’s anti-COVID-19 DARPin programme, which consists …

lilly_building_with_american_flag_web

US reserves 300,000 doses of Lilly’s COVID-19 treatment in $375 million deal

October 28, 2020
Manufacturing and Production, Research and Development, Sales and Marketing COVID-19, Eli Lilly, US, pharma

The US Government has signed a $375 million deal with Eli Lilly to buy 300,000 700mg doses of bamlanivimab, its …

80% of COVID-19 patients in study were vitamin D-deficient

October 28, 2020
Research and Development

New research has found that over 80% of COVID-19 patients in a recent study had a vitamin D deficiency.  The …

The Gateway to Local Adoption Series

Latest content